312 related articles for article (PubMed ID: 24490758)
1. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
Salmani JM; Lv H; Asghar S; Zhou J
Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
[TBL] [Abstract][Full Text] [Related]
3. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
Prabhu P; Patravale V
Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
[TBL] [Abstract][Full Text] [Related]
4. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
[TBL] [Abstract][Full Text] [Related]
5. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
Khan FN; Dehghan MH
AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
7. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.
Aldosari BN; Almurshedi AS; Alfagih IM; AlQuadeib BT; Altamimi MA; Imam SS; Hussain A; Alqahtani F; Elzayat E; Alshehri S
AAPS PharmSciTech; 2021 May; 22(5):161. PubMed ID: 34031791
[TBL] [Abstract][Full Text] [Related]
10. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
11. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
12. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
Ali KA; Mukherjee B; Bandyopadhyay AK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1742-9. PubMed ID: 23216220
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic insight into the dramatic improvement of probucol dissolution in neutral solutions by solid dispersion in Eudragit E PO with saccharin.
Higashi K; Seo A; Egami K; Otsuka N; Limwikrant W; Yamamoto K; Moribe K
J Pharm Pharmacol; 2016 May; 68(5):655-64. PubMed ID: 26272472
[TBL] [Abstract][Full Text] [Related]
14. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique.
Park JH; Choi HK
Arch Pharm Res; 2015 Jul; 38(7):1336-44. PubMed ID: 25567762
[TBL] [Abstract][Full Text] [Related]
17. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
[TBL] [Abstract][Full Text] [Related]
19. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and
Dong W; Su X; Xu M; Hu M; Sun Y; Zhang P
Asian J Pharm Sci; 2018 Nov; 13(6):546-554. PubMed ID: 32211078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
